LanzaTech appoints Zara Summers as CSO, Michael Kopke as CIO

LanzaTech Global announced the promotion of Dr. Zara Summers to Chief Science Officer and Dr. Michael Kopke to Chief Innovation Officer. In her new role, Dr. Summers will oversee the entirety of LanzaTech’s Science division – which encompasses Synthetic Biology, Fermentation, AI, and Computational Biology – unifying and streamlining the Company’s R&D work for commercial success. She will have accountability for the Company’s technology pipeline and technical portfolio. Prior to the promotion, Dr. Summers served as LanzaTech’s VP of Science. Dr. Kopke will oversee the process of innovation within the Company, including identifying next technology breakthroughs, developing and incubating technology and business opportunities for LanzaTech, and increasing organizational resilience and flexibility through its technology investments. He will continue to play a leading role in establishing and coordinating technology partnerships and innovation networks and will lead a Distinguished Technical Council at LanzaTech, that will lead on cutting edge developments that can support the Company’s commercial pipeline. Prior to the promotion, Dr. Kopke most recently served as LanzaTech’s VP of Synthetic Biology.